The Coronavirus Pandemic (SARS-CoV-2): New Problems Demand New Solutions, the Alternative of Mesenchymal (Stem) Stromal Cells

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2020 Aug 9

PMID 32766251

Citations 10

Authors

Noemi Eiro

Jorge Ruben Cabrera

Maria Fraile

Luis Costa

Francisco J Vizoso

Affiliations

Soon will be listed here.

Abstract

Mesenchymal (stem) stromal cells (MSC) can be a therapeutic alternative for COVID-19 considering their anti-inflammatory, regenerative, angiogenic, and even antimicrobial capacity. Preliminary data point to therapeutic interest of MSC for patients with COVID-19, and their effect seems based on the MSC's ability to curb the cytokine storm caused by COVID-19. In fact, promising clinical studies using MSC to treat COVID-19, are currently underway. For this reason, now is the time to firmly consider new approaches to MSC research that addresses key issues, like selecting the most optimal type of MSC for each indication, assuming the heterogeneity of the donor-dependent MSC and the biological niche where MSC are located.

Citing Articles

Pulmonary and Systemic Immune Profiles Following Lung Volume Reduction Surgery and Allogeneic Mesenchymal Stromal Cell Treatment in Emphysema.

Jia L, Li N, van Unen V, Zwaginga J, Braun J, Hiemstra P Cells. 2024; 13(19.

PMID: 39404398 PMC: 11476308. DOI: 10.3390/cells13191636.

Extracellular vesicles as tools and targets in therapy for diseases.

Kumar M, Baba S, Sadida H, Al Marzooqi S, Jerobin J, Altemani F Signal Transduct Target Ther. 2024; 9(1):27.

PMID: 38311623 PMC: 10838959. DOI: 10.1038/s41392-024-01735-1.

Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities.

Nova Z, Zemanek T, Botek N Int J Mol Sci. 2022; 23(23).

PMID: 36499448 PMC: 9737069. DOI: 10.3390/ijms232315122.

Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times.

Vizoso F, Fernandez-Francos S, Eiro N Int J Mol Sci. 2021; 22(16).

PMID: 34445102 PMC: 8395045. DOI: 10.3390/ijms22168395.

Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.

Fernandez-Francos S, Eiro N, Gonzalez-Galiano N, Vizoso F Int J Mol Sci. 2021; 22(15).

PMID: 34360616 PMC: 8346146. DOI: 10.3390/ijms22157850.

References

Schweitzer K, Johnstone B, Garrison J, Rush N, Cooper S, Traktuev D . Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med. 2010; 183(2):215-25. PMC: 3040390. DOI: 10.1164/rccm.201001-0126OC. View

Atluri S, Manchikanti L, Hirsch J . Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Pain Physician. 2020; 23(2):E71-E83. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Schneider J, Eiro N, Perez-Fernandez R, Martinez-Ordonez A, Vizoso F . Human Uterine Cervical Stromal Stem Cells (hUCESCs): Why and How they Exert their Antitumor Activity. Cancer Genomics Proteomics. 2016; 13(5):331-7. PMC: 5070623. View

Backer J, Klinkenberg D, Wallinga J . Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Euro Surveill. 2020; 25(5). PMC: 7014672. DOI: 10.2807/1560-7917.ES.2020.25.5.2000062. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Chen J, Hu C, Chen L, Tang L, Zhu Y, Xu X . Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment. Engineering (Beijing). 2020; 6(10):1153-1161. PMC: 7102606. DOI: 10.1016/j.eng.2020.02.006. View

Bernard O, Jeny F, Uzunhan Y, Dondi E, Terfous R, Label R . Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signaling. Am J Physiol Lung Cell Mol Physiol. 2017; 314(3):L360-L371. DOI: 10.1152/ajplung.00153.2017. View

Khatri M, Richardson L, Meulia T . Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018; 9(1):17. PMC: 5789598. DOI: 10.1186/s13287-018-0774-8. View

10.

Chan M, Kuok D, Leung C, Hui K, Valkenburg S, Lau E . Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo. Proc Natl Acad Sci U S A. 2016; 113(13):3621-6. PMC: 4822574. DOI: 10.1073/pnas.1601911113. View

11.

Li J, Wu X . Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fluid clearance of alveolar type II cells. Eur Rev Med Pharmacol Sci. 2015; 19(13):2368-78. View

12.

Ribeiro-Paes J, Bilaqui A, Greco O, Ruiz M, Marcelino M, Stessuk T . Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. Int J Chron Obstruct Pulmon Dis. 2011; 6:63-71. PMC: 3034284. DOI: 10.2147/COPD.S15292. View

13.

Antunes M, Lapa E Silva J, Rocco P . Mesenchymal stromal cell therapy in COPD: from bench to bedside. Int J Chron Obstruct Pulmon Dis. 2017; 12:3017-3027. PMC: 5652911. DOI: 10.2147/COPD.S146671. View

14.

Bari E, Ferrarotti I, Torre M, Corsico A, Perteghella S . Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation. J Control Release. 2019; 309:11-24. DOI: 10.1016/j.jconrel.2019.07.022. View

15.

McIntyre L, Moher D, Fergusson D, Sullivan K, Mei S, Lalu M . Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review. PLoS One. 2016; 11(1):e0147170. PMC: 4731557. DOI: 10.1371/journal.pone.0147170. View

16.

Ntolios P, Manoloudi E, Tzouvelekis A, Bouros E, Steiropoulos P, Anevlavis S . Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. Clin Respir J. 2018; 12(6):2084-2089. DOI: 10.1111/crj.12777. View

17.

Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H . Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2017; 172(3):423-438.e25. PMC: 5786493. DOI: 10.1016/j.cell.2017.11.018. View

18.

Collino F, Deregibus M, Bruno S, Sterpone L, Aghemo G, Viltono L . Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One. 2010; 5(7):e11803. PMC: 2910725. DOI: 10.1371/journal.pone.0011803. View

19.

Cruz F, Borg Z, Goodwin M, Sokocevic D, Wagner D, Coffey A . Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice. Stem Cells Transl Med. 2015; 4(11):1302-16. PMC: 4622402. DOI: 10.5966/sctm.2014-0280. View

20.

Akram K, Patel N, Spiteri M, Forsyth N . Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic Approaches. Int J Mol Sci. 2016; 17(1). PMC: 4730369. DOI: 10.3390/ijms17010128. View